Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urinary Bladder Neoplasms 2Urinary Incontinence 1Nocturnal Enuresis 1Neoplasms 1Diurnal Enuresis 1

Interventions

Docetaxel 229Radiotherapy 206Magnetic Resonance Spectroscopy 204Radiosurgery 176Gemcitabine 155pembrolizumab 151Nivolumab 147enzalutamide 140Prednisone 129Cisplatin 123Leuprolide 119Androgen Antagonists 117Abiraterone Acetate 114Sunitinib 106Specimen Handling 94Surveys and Questionnaires 91Goserelin 91bicalutamide 90Carboplatin 88Ipilimumab 82gallium 68 PSMA-11 80Blood Specimen Collection 78Everolimus 73apalutamide 72Radiation 71Standard of Care 68Biopsy 68acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 66Paclitaxel 64Cyclophosphamide 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × mebeverine × Genitourinary × Clear all
NCT04635566 2020-11-19

Pharmacological Enhancement for Nocturnal Incontinence in Orthotopic Bladder Substitute

Mansoura University

Phase NA Completed
120 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urinary Incontinence

NCT03147599 2020-06-30

Mebeverine For 1st Year Daytime And Nocturnal Incontinence After Orthotopic W-Ileal Neobladders

Mansoura University

Phase 4 Completed
110 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplasms, Nocturnal Enuresis, Diurnal Enuresis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡